blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP1379517

EP1379517 - ABCA-1 ELEVATING COMPOUNDS AGAINST CORONARY ARTERY DISEASE OR ATHEROSCLEROSIS [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  19.11.2010
Database last updated on 19.07.2024
Most recent event   Tooltip19.11.2010Application deemed to be withdrawnpublished on 22.12.2010  [2010/51]
Applicant(s)For all designated states
CV THERAPEUTICS, INC.
3172 Porter Drive
Palo Alto, CA 94304 / US
[2004/03]
Inventor(s)01 / CAMPBELL, Michael
5925 Rusticwood Lane
Durham, NC 27713 / US
02 / IBRAHIM, Prabha, N.
3380 Lubich Dr.
Mountain View, CA 94041 / US
03 / ZABLOCKI, Jeff, A.
1910 Noel Drive
Los Altos, CA 94024 / US
04 / LAWN, Richard
1927 8th Avenue
San Francisco, CA 94116 / US
 [2009/04]
Former [2004/03]01 / CAMPBELL, Michael
5925 Rusticwood Lane
Durham, NC 27713 / US
02 / IBRAHIM, Prabha, N.
3380 Lubich Dr.
Mountain View, CA 94041 / US
03 / ZABLOCKI, Jeff, A.
580 Sleeper Ave.
Mountain View, CA 94040 / US
04 / LAWN, Richard
1927 8th Avenue
San Francisco, CA 94116 / US
Representative(s)Vossius, Volker, et al
ZSP Patentanwälte PartG mbB
Radlkoferstrasse 2
81373 München / DE
[N/P]
Former [2008/33]Vossius, Volker, et al
Dr. Volker Vossius Patentanwaltskanzlei - Rechtsanwaltskanzlei Geibelstrasse 6
81679 München / DE
Former [2004/03]Vossius, Volker, Dr., et al
Patent- und Rechtsanwaltskanzlei Geibelstrasse 6
81679 München / DE
Application number, filing date01995408.006.12.2001
[2004/03]
WO2001US46979
Priority number, dateUS20000251916P07.12.2000         Original published format: US 251916 P
US20010313274P17.08.2001         Original published format: US 313274 P
[2004/03]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report
No.:WO0246181
Date:13.06.2002
Language:EN
[2002/24]
Type: A2 Application without search report 
No.:EP1379517
Date:14.01.2004
Language:EN
The application published by WIPO in one of the EPO official languages on 13.06.2002 takes the place of the publication of the European patent application.
[2004/03]
Search report(s)International search report - published on:EP27.12.2002
ClassificationIPC:C07D319/08
[2004/03]
CPC:
C07D319/08 (EP,US); A61K31/357 (KR); A61K31/53 (EP,US);
A61K45/06 (EP,US); A61P3/06 (EP); A61P43/00 (EP);
A61P9/00 (EP); A61P9/10 (EP); C07C237/06 (EP,US);
C07C237/22 (EP,US); C07C237/40 (EP,US); C07C275/26 (EP,US);
C07C311/20 (EP,US); C07C323/36 (EP,US); C07C323/40 (EP,US);
C07C323/60 (EP,US); C07C327/42 (EP,US); C07C327/48 (EP,US);
C07D251/16 (EP,US); C07D251/52 (EP,US); C07D409/12 (EP,US);
C07C2601/08 (EP,US); C07C2601/14 (EP,US); C07C2602/10 (EP,US);
C07C2602/40 (EP,US); C07C2602/42 (EP,US); C07C2603/74 (EP,US) (-)
C-Set:
A61K31/53, A61K2300/00 (EP,US)
Designated contracting statesAT,   BE,   CH,   CY,   DE,   DK,   ES,   FI,   FR,   GB,   GR,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   SE,   TR [2004/03]
Extension statesAL07.07.2003
LT07.07.2003
LV07.07.2003
MK07.07.2003
RO07.07.2003
SI07.07.2003
TitleGerman:ABCA-1-EXPRESSIONS-STIMULIERENDE VERBINDUNGEN GEGEN KORONARARTERIEN-ERKRANKUNGEN ODER ATHEROSCLEROSE[2004/03]
English:ABCA-1 ELEVATING COMPOUNDS AGAINST CORONARY ARTERY DISEASE OR ATHEROSCLEROSIS[2004/03]
French:COMPOSES ELEVANT L'ABCA-1 CONTRE LES MALADIES CORONAIRES ET L'ATHEROSCLEROSE[2004/03]
Entry into regional phase04.07.2003National basic fee paid 
04.07.2003Designation fee(s) paid 
04.07.2003Examination fee paid 
Examination procedure10.06.2002Request for preliminary examination filed
International Preliminary Examining Authority: EP
04.07.2003Amendment by applicant (claims and/or description)
04.07.2003Examination requested  [2004/03]
08.03.2007Despatch of a communication from the examining division (Time limit: M06)
13.09.2007Reply to a communication from the examining division
04.04.2008Despatch of a communication from the examining division (Time limit: M04)
04.08.2008Reply to a communication from the examining division
26.09.2008Despatch of a communication from the examining division (Time limit: M04)
03.02.2009Reply to a communication from the examining division
18.02.2010Communication of intention to grant the patent
29.06.2010Application deemed to be withdrawn, date of legal effect  [2010/51]
05.08.2010Despatch of communication that the application is deemed to be withdrawn, reason: fee for grant / fee for printing not paid in time  [2010/51]
Fees paidRenewal fee
29.12.2003Renewal fee patent year 03
23.12.2004Renewal fee patent year 04
27.12.2005Renewal fee patent year 05
27.12.2006Renewal fee patent year 06
24.12.2007Renewal fee patent year 07
24.12.2008Renewal fee patent year 08
Penalty fee
Additional fee for renewal fee
31.12.200909   M06   Not yet paid
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[X]US4971957  (TSUTSUMI KAZUHIKO [JP], et al) [X] 1,21,31-37,39,59,70 * Summary; columns 27-28; table 4; claim 1; examples 45, 46, 52, 54. *;
 [X]EP0636619  (SANKYO CO [JP]) [X] 1,2,11,31-37,39,40,49,70 * Summary; claims 1, 8, 21; examples e.g. 1-71 to 1-74 and 1-89 to 1-94 on page 9. *;
 [A]EP0718285  (AMERICAN CYANAMID CO [US]) [A] 1-70* Page 1, lines 43-46. *;
 [X]US5776951  (ARROWSMITH RICHARD JAMES [GB], et al) [X] 1-3,11,12,31-37,39-41,49,50,70 * Abstract; claim 1; column 28, example 65. *;
 [X]WO9941239  (NOVARTIS AG [CH], et al) [X] 39,70 * Claim 2; and pages 9-10, examples 12,13. *;
 [X]US6008230  (OKU TERUO [JP], et al) [X] 39,59-61,70 * Columns 120-121, example 235: 8-(2-aminobenzoylamino)-3-bromoquinoline, 8-(2-acetamidobenzoylamino)-3-bromoquino- line. *;
 [A]WO0005201  (NOVARTIS AG [CH], et al) [A] 1-70 * Abstract; page 20, paragraph 3; claim 1; examples. *;
 [X]WO0027820  (NOVARTIS AG [CH], et al) [X] 39,59,70 * Claims 1, and 12-14. *;
 [X]WO0027819  (SCHERING AG [DE], et al) [X] 39,59,70 * Claim 3; examples e.g. numbers 2.26, 2.34, 2.51, 2.52, 2.55. *;
 [X]  - CROSSFIRE BEILSTEIN, Beilstein Institut zur Foerderung der Wissenschaften, Frankfurt am Main, DE, XP002199657 [X] 39,59-62 * Database-Accession no. 2128674 (BRN) *
    [ ] - J. CHEM. SOC. PERKIN TRANS. 1, (1979) [ ] * pages 2203,2205,2206. *
 [X]  - CROSSFIRE BEILSTEIN, Beilstein Institut zur Foerderung der Wissenschaften, Frankfurt am Main, DE, XP002199658 [X] 39,59-61 * Database-Accession no. 2180011 (BRN) *
    [ ] - INDIAN J. CHEM., (1974), vol. 12, pages 1212 - 1215
 [X]  - CROSSFIRE BEILSTEIN, Beilstein Institut zur Foerderung der Wissenschaften, Frankfurt am Main, DE, XP002199659 [X] 39,59-61 * Database-Accession no. 2944641 (BRN) *
    [ ] - Z. NATURFORSCH. B ANORG. CHEM. ORG. CHEM., (1974), vol. 29, page 575
 [X]  - CROSSFIRE BEILSTEIN, Beilstein Institut zur Foerderung der Wissenschaften, Frankfurt am Main, DE, XP002199660 [X] 39,59-61 * Database-Accession no. 3383120 (BRN) *
    [ ] - CHEM. BER., (1948), vol. 81 [ ] * pages 45, 49. *
 [X]  - CROSSFIRE BEILSTEIN, Beilstein Institut zur Foerderung der Wissenschaften, Frankfurt am Main, DE, XP002199661 [X] 39,59-61,65 * Database-Accession no. 5480687 (BRN) *
    [ ] - INDIAN J. CHEM. SECT. B, (1992), vol. 31, no. 3, pages 177 - 182
ExaminationEP0293839
 WO0110842
    - Database Beilstein, BRN's 2173483, 2168227, 2168289.
    - Database Beilstein, BRN 2999040.
    - Database Beilstein, BRN's 3391653, 4264394, 4264950, 4265431.
    - Database Beilstein, BRN's 3444481, 3479916.
    - Database Beilstein, BRN 1601717.
    - Database Beilstein, BRN's 3503016, 3184438.
    - Database Beilstein, BRN's 6226691, 6230673, 6224752, 6229179.
    - Database Beilstein, BRN 3174982.
    - Database Beilstein, BRN's 6207294, 6238506.
    - Database CAPLUS, AN 1997:8137, RN 185900-37-2.
    - Database CAPLUS, AN 2001:115125, RNs 326485-41-0, 326485-45-4, 326485-64-7, 325823-78-7, 325826-44-6, 325826-51-5, 325826-57-1, 325828-25-9, 325828-26-0, 326482-66-0, 326484-33-7, 326484-34-8, 326484-47-3, 326484-49-5, 326484-50-8, 326484-77-9, 326484-78-0.
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.